Please login to the form below

Not currently logged in

EMA to review experimental Ebola drugs

European Medicines Agency (EMA)

Response comes as death-toll tops 3,000

PD1 drugs could end 'decades of silence' in bladder cancer therapy

TabletsMerck's Keytruda and Roche antibody showing promise

Janssen, AZ and Roche at ESMO

esmo congress madridCompanies present promising data on new cancer drugs

Amag buys into maternal health business

AMAG pharma logoWill acquire female health specialist Lumara Health

Japan's Daiichi Sankyo pays $410m for Ambit Biosciences

Daiichi Sankyo logoGains rights to cancer drug quizartinib

EMA wants to embed patient viewpoint within drug assessment

Will pilot CHMP benefit-risk evaluation project

Gilead’s hep C combination Harvoni recommended for EU approval

Gilead SciencesCHMP backs combination of Sovaldi and ledipasvir

Sanofi provides bursaries to UK patient groups

Sanofi receptionOlder People's Advocacy Alliance receives gold award of £25,000


Economic issues impact skilled labour

Report shows widening gap between what skills people can offer and what employers are looking for

price is right efpiaThe price is right: drug reimbursement in Europe

EFPIA's director general argues that drug pricing is not a gameshow

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company
Blue Latitude

We are experts in customer engagement. A strategic multichannel marketing and customer experience agency, specialising in pharmaceuticals, medical devices, and...

Latest intelligence

access denied
Sales reps struggle to access doctors
Doctors continue to turn away from face-to-face visits from pharma sales reps and look instead towards mobile technology for information...
Online Physician Communities
Research finds doctors are optimistic about new diabetes drugs but concerned over rationing
New data from M3 Global Research shows that clinicians buy in to the effectiveness of new diabetes therapies. However, they are concerned about rationing and believe that more resources are...
The heart of the matter: Part Two
How is social media impacting publication planning?...